{
    "clinical_study": {
        "@rank": "139647", 
        "arm_group": {
            "arm_group_label": "Supreme Laryngeal Mask Airway", 
            "arm_group_type": "Other", 
            "description": "Supreme Laryngeal Mask Airway with gastric tube. Preoxygenation, rapid sequence induction and cricoid pressure. Induction of general anaesthesia."
        }, 
        "brief_summary": {
            "textblock": "The Supreme Laryngeal Mask Airway (SLMA) is a single use supraglottic device that provides a\n      good seal for positive pressure ventilation and good first attempt insertion rate of 98% in\n      low risk patients undergoing elective Caesarean section. It has a double aperture design\n      that facilitates the introduction of an orogastric tube to aspirate gastric contents.\n\n      The primary study hypothesis is the first attempt insertion success rate of SLMA use in\n      urgent Caesarean section."
        }, 
        "brief_title": "Supreme LMA Use in Urgent Caesarean Section", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Airway Morbidity", 
        "detailed_description": {
            "textblock": "Investigators propose a prospective cohort study to study the first attempt insertion\n      success rate of supreme LMA in general anaesthesia for urgent caesarean section."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18 to 50 years old\n\n          -  American Society of Anesthesiology status 1 or 2\n\n          -  Weight 40 to 75kg\n\n          -  Normal airway assessment\n\n          -  Term pregnancy (36 weeks or more)\n\n          -  Urgent Caesarean Section\n\n        Exclusion Criteria:\n\n          -  Body mass index (35 or more)\n\n          -  Difficult airway (Mallampati 4 or abnormal airway assessment)\n\n          -  Gastrooesophageal reflux"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02026882", 
            "org_study_id": "2013-11-11"
        }, 
        "intervention": {
            "arm_group_label": "Supreme Laryngeal Mask Airway", 
            "description": "Supreme Laryngeal Mask Airway. Preoxygenation, rapid sequence induction and cricoid pressure. Induction of general anaesthesia.", 
            "intervention_name": "Supreme Laryngeal Mask Airway", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Airway, Caesarean", 
        "lastchanged_date": "December 31, 2013", 
        "location": {
            "contact": {
                "email": "ywyzxy@sina.com", 
                "last_name": "Wei Y Yao, MD", 
                "phone": "+8613959790011"
            }, 
            "facility": {
                "address": {
                    "city": "Quanzhou", 
                    "country": "China", 
                    "state": "Fujian", 
                    "zip": "700"
                }, 
                "name": "Quanzhou Women's and Children's Hospital"
            }, 
            "investigator": {
                "last_name": "Wei Y Yao, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "Supreme Laryngeal Mask Use in Urgent Caesarean Section", 
        "overall_contact": {
            "email": "ywyzxy@sina.com", 
            "last_name": "Wei Y Yao, MD", 
            "phone": "+8613959790011"
        }, 
        "overall_contact_backup": {
            "email": "blsngdr@yahoo.com.sg", 
            "last_name": "Ban L Sng, FANZCA", 
            "phone": "+6563941081"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "An attempt is defined as insertion and withdrawal of the device from the patient's airway", 
            "measure": "First attempt insertion success rate", 
            "safety_issue": "No", 
            "time_frame": "1 hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02026882"
        }, 
        "responsible_party": {
            "investigator_affiliation": "QuanZhou Women and Children's Hospital", 
            "investigator_full_name": "Wei Yu Yao", 
            "investigator_title": "Dr", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Interval from when the device was picked up until appearance of the first end-tidal carbon dioxide waveform", 
                "measure": "Time to effective airway placement", 
                "safety_issue": "No", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "Signs of aspiration as evidenced by perioperative hypoxaemia, wheezing or crepitations upon auscultation of lungs or postoperative dyspnoea with chest x ray signs of aspiration", 
                "measure": "Aspiration", 
                "safety_issue": "Yes", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "inspection for presence of blood upon removal of SLMA", 
                "measure": "blood on SLMA on removal", 
                "safety_issue": "Yes", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "Sore throat present in recovery room", 
                "measure": "Sore throat", 
                "safety_issue": "Yes", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "Gastric contents identified in the mouth with pH less than 4", 
                "measure": "Regurgitation", 
                "safety_issue": "Yes", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "Recorded by closing the adjustable pressure limiting valve and insufflating the closed breathing system with 3L/min fresh gas flow. The peak circuit airway pressure achieved will be recorded.", 
                "measure": "Seal pressure", 
                "safety_issue": "Yes", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "Volume of gastric aspirate using gastric tube and pH of gastric aspirate using litmus paper", 
                "measure": "Gastric aspirate", 
                "safety_issue": "Yes", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "Neonatal birthweight. APGAR score. Umbilical venous cord pH", 
                "measure": "Neonatal outcomes", 
                "safety_issue": "Yes", 
                "time_frame": "1 hour"
            }
        ], 
        "source": "QuanZhou Women and Children's Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "KK Women's and Children's Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "QuanZhou Women and Children's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}